Title: | Spinal Muscular Atrophy Therapies: ICER Grounds the Price to Value Conversation in Facts |
Journal : | Journal of managed care & specialty pharmacy, 25, 12 |
Authors: | Starner CI, Author ; Gleason PP |
Material Type: | Article |
Publisher: | United States, 12/2019 |
Size: | p 1306 |
Languages: | English |
Keywords : | antisense oligonucleotides ; benefice-to-cost analysis ; comment ; gene therapy ; neuromuscular disease ; nusinersen ; onasemnogene abeparvovec-xioi ; SMN1-related proximal spinal muscular atrophy ; spinal muscular atrophy |
Pubmed / DOI : | Pubmed : 31778615 / DOI : 10.18553/jmcp.2019.25.12.1306 |
N° Profil MNM : | 2019121 |
Link for e-copy: | http://www.ncbi.nlm.nih.gov/pubmed/31778615 |